Impact of Inhibitors of the Renin-Angiotensin-Aldosterone System on Liver Fibrosis and Portal Hypertension

E-ISSN： 1875-533x|13|30|3649-3661

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.13, Iss.30, 2006-01, pp. : 3649-3661

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of the Renin-Angiotensin-Aldosterone System in the Pathogenesis of Atherosclerosis

Current Pharmaceutical Design, Vol. 18, Iss. 7, 2012-03 ,pp. : 981-1004

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of Losartan on the Renin-Angiotensin-Aldosterone System and Erythrocytosis in Patients with Chronic Obstructive Pulmonary Disease and Systemic Hypertension

By Füsun ülger A.

Clinical Drug Investigation, Vol. 21, Iss. 5, 2001-01 ,pp. : 337-343

Adis International

Access to resources Recommend Favorite

Possible Involvement of Angiogenesis in Chronic Liver Diseases: Interaction Among Renin-Angiotensin-Aldosterone System, Insulin Resistance and Oxidative Stress

Current Medicinal Chemistry, Vol. 19, Iss. 12, 2012-01 ,pp. : 1889-1898

Bentham Science Publishers

Access to resources Recommend Favorite

Genetic polymorphisms related to the renin–angiotensin–aldosterone system and response to antihypertensive drugs

By Taverne Kim de Groot Mark de Boer Anthonius Klungel Olaf

Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, Iss. 4, 2010-04 ,pp. : 439-460

Informa Healthcare

Access to resources Recommend Favorite

Modulation of the renin–angiotensin–aldosterone system in sepsis: a new therapeutic approach?

By Salgado Diamantino Ribeiro Rocco José Rodolfo Silva Eliézer Vincent Jean-Louis

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 1, 2010-01 ,pp. : 11-20

Informa Healthcare

Access to resources Recommend Favorite